IBEX Limited (“ibex”), a leading provider in global business
process outsourcing and end-to-end customer engagement technology
solutions, today announced financial results for its fourth quarter
and fiscal year ended June 30, 2023.
Key Fiscal Year 2023
Highlights
- Fiscal year 2023 revenue increased
6.1% over the prior year period to $523.1 million, with a continued
migration from onshore to higher margin offshore and nearshore
regions.
- Revenue generated from BPO 2.0
clients grew at an accelerated rate and increased 18.5% for fiscal
year 2023. These clients represented 77% of revenue for the fiscal
year.
- Ten new client relationships were
established across the HealthTech, Retail & E-Commerce, Travel,
Transportation & Logistics, and Technology verticals during
fiscal year 2023.
- Fiscal year 2023 GAAP net income
and diluted earnings per share increased to $31.6 million and $1.67
from $21.5 million and $1.15 in the prior year, respectively. Net
income margins in the full year were 6.0%, an increase of 168 bps
for the year.
- Fiscal year 2023 adjusted net
income and adjusted earnings per share increased to $36.9 million
and $1.96 from $26.0 million and $1.39 in the prior year.
- Fiscal year 2023 adjusted EBITDA
increased 48.8% to $66.6 million, over the prior year. Adjusted
EBITDA margins in the full year were 12.7%, an increase of 360 bps
for the year.
- Capacity utilization increased to
77% at June 30, 2023 from approximately 69% at June 30, 2022,
contributing to the significant margin improvement.
- Net cash position improved to $56.4
million as of June 30, 2023 from $33.1 million as of June 30, 2022
due to strong free cash flow generated throughout the year (see
Exhibit 4 for reconciliation).
- Results in line with guidance on a
US GAAP basis.
Key Fourth Quarter 2023
Highlights
- Fourth quarter revenue increased
0.7% to $124.4 million over the prior year quarter.
- Fourth quarter GAAP net income and
diluted earnings per share declined to $4.5 million, and $0.24
compared to $6.4 million, and $0.35 in the prior year quarter,
driven largely by the absence of a one-time deferred tax benefit in
the prior year quarter. Net income margin was 3.6% compared to 5.2%
in the prior year quarter.
- Fourth quarter adjusted net income
and adjusted earnings per share declined to $6.2 million and $0.33
compared to $8.3 million and $0.45 in the prior year quarter,
driven largely by the absence of a one-time deferred tax benefit in
prior year quarter.
- Fourth quarter non-GAAP adjusted
EBITDA increased 21.0% to $15.4 million, over the prior year
quarter.
- Adjusted EBITDA margins in the
fourth quarter were 12.4%, +210 bps in the quarter.
“In the face of a challenging macro-environment,
ibex delivered outstanding financial results in fiscal year 2023,”
said Bob Dechant, CEO of ibex. “Our business grew at 6% annually,
driven by new wins with blue chip clients in our strategic
verticals, while adjusted EBITDA grew at an impressive 49%. We made
meaningful progress on growth in our key HealthTech and Retail
& E-Commerce verticals, as well as our geographic footprint and
capacity utilization.” Dechant continued, “We finished the year
with continued strong margin expansion and have our pipeline and
sales funnel in a great position. Additionally, with our leadership
position in developing AI based solutions, I am very optimistic
about the long-term trajectory of ibex in fiscal year 2024 and
beyond.”
Domestic filing status and US GAAP
conversionAs of July 1, 2023, we became a domestic filer
and are reporting our financial results in accordance with US GAAP,
rather than IFRS. The two significant accounting impacts from this
change are in lease and warrant accounting. Among the impacts, this
results in a reduction in reported debt of $77.9 million as of June
30, 2023, a reduction in fourth quarter and fiscal year 2023
reported revenue of $0.02 million and $0.2 million, respectively,
and a reduction in reported fourth quarter and fiscal year 2023
adjusted EBITDA of $5.3 million and $21.9 million, respectively,
compared to what would have been reported under IFRS. When these
impacts are factored into our previously provided guidance issued
under IFRS, the results align with our previous guidance.
Fiscal Year 2023 Financial
PerformanceRevenue
- Revenue increased 6.1% to $523.1
million compared to $492.9 million in the prior year as we
successfully grew in our strategic verticals while replacing a
large legacy technology client.
- Revenue growth was primarily driven
by strength in our HealthTech, Retail & E-Commerce, Travel and
Transportation & Logistics verticals.
- The Telecom vertical now represents
16.3% of our annual revenue, compared to 18.1% in the prior year,
as we continue diversifying our client base.
Net Income and Earnings Per Share
- Net income and diluted earnings per
share increased to $31.6 million and $1.67, respectively, compared
to $21.5 million and $1.15, respectively, in the prior year. The
improvement was primarily driven by stronger operating results from
higher capacity utilization and an increased mix of higher margin
nearshore and offshore delivery.
- Net income margin was 6.0%,
compared to 4.4% in the prior year.
- Non-GAAP adjusted net income and
diluted adjusted earnings per share increased to $36.9 million and
$1.96, respectively, compared to $26.0 million and $1.39,
respectively, in the prior year (see Exhibit 1 for
reconciliation).
Adjusted EBITDA
- Adjusted EBITDA increased to $66.6
million, compared to $44.7 million in the prior year (see Exhibit 2
for reconciliation), driven by stronger operating results from
higher capacity utilization and an increased mix of higher margin
nearshore and offshore delivery.
- Adjusted EBITDA margin was 12.7%,
compared to 9.1% in the prior year (see Exhibit 2 for
reconciliation).
Fourth Quarter Financial
PerformanceRevenue
- Revenue increased 0.7% to $124.4
million, compared to $123.5 million in the prior year quarter.
Revenue growth was driven by 10% growth in our higher margin near
and offshore regions, offset by lower onshore revenue, and was
moderated by prevailing macroeconomic market conditions. Revenues
in our higher margin offshore and nearshore regions represented
73.9% of revenue mix for the quarter versus 67.8% in the prior year
quarter.
- Revenue related to our BPO 2.0
clients grew 7.0% compared to the prior year quarter and now
represents 78.8% of our quarterly revenue.
Net Income and Earnings Per Share
- Net income decreased to $4.5
million compared to $6.4 million in the prior year quarter. Diluted
earnings per share decreased to $0.24 compared to $0.35 in the
prior year quarter. The decrease was primarily the result of higher
taxes due to the absence of a one-time tax benefit in the prior
year quarter.
- Net income margin decreased to 3.6%
compared to 5.2% in the prior year quarter.
- Non-GAAP adjusted net income was
$6.2 million, compared to $8.3 million in the prior year quarter.
Non-GAAP adjusted diluted earnings per share decreased to $0.33,
compared to $0.45 in the prior year quarter (see Exhibit 1 for
reconciliation). The decline was largely the result of a one-time
tax benefit in the prior year quarter.
Adjusted EBITDA
- Adjusted EBITDA increased to $15.4
million, compared to $12.8 million in the prior year quarter (see
Exhibit 2 for reconciliation), driven by stronger operating results
from higher capacity utilization and an increased mix of higher
margin nearshore and offshore delivery.
- Adjusted EBITDA margin increased to
12.4%, compared to 10.3% in the prior year quarter (see Exhibit 2
for reconciliation).
Fiscal 2023 Year End Cash Flow and
Balance Sheet
- Cash flow from operations increased
to $41.9 million, compared to $40.0 million in the prior year. The
increase was primarily driven by improvements in operating results,
offset by higher working capital requirements.
- Capital expenditures were $19.0
million compared to $25.9 million in the prior year.
- Full year free cash flow increased
to $22.9 million, compared to $14.1 million in the prior year (see
Exhibit 3 for reconciliation).
- Cash and cash equivalents improved
to $57.4 million and availability on our revolving credit
facilities was $71.9 million as of June 30, 2023, compared to cash
and cash equivalents of $48.8 million and availability on our
revolving credit facilities of $50.5 million as of June 30,
2022.
- Total debt was $1.0 million as of
June 30, 2023, compared to total debt of $15.7 million last
year.
- Net cash position improved to $56.4
million as of June 30, 2023 from $33.1 million as of June 30, 2022
(see Exhibit 4 for reconciliation).
Fiscal Year and First Quarter Fiscal
2024 Business Outlook“Looking ahead to fiscal year 2024,
while the sales pipeline remains healthy, we expect the
macroeconomic environment and trend toward lower cost, higher
margin regions will continue to impact revenue growth. The impact
of the operational improvements we’ve made to our business and
margin structure will carry forward, which enables us to further
invest in our infrastructure for the future, as we focus on revenue
growth and continued EBITDA margin expansion,” said Taylor
Greenwald, CFO of ibex. “We view ibex as a business that will
resume to historical growth rates with continued margin expansion
over the longer term.”
- For fiscal year 2024 revenue is expected to be in the range of
$525 to $535 million, representing low single-digit growth.
Adjusted EBITDA margin should increase to approximately 13%.
- For the first quarter fiscal 2024 revenue is expected to be in
the range of $122 to $125 million, reflective of the macroeconomic
impacts. Adjusted EBITDA margin should increase to approximately
11% versus 10% in the prior year quarter on a US GAAP basis.
- Fiscal year 2024 capital expenditures are expected to be in the
range of $15 to $20 million.
Conference Call and Webcast
InformationIBEX Limited will host a conference call and
live webcast to discuss its fourth quarter of fiscal year 2023
financial results at 4:30 p.m. eastern time today, September 13,
2023. The conference e-call may be accessed by registering at here.
We will also post to this section of our website the earning
slides, which will accompany our conference call and live webcast,
and encourage you to review the information that we make available
on our website.
Live and archived webcasts can be accessed
at: https://investors.ibex.co/.
Financial InformationThis
announcement does not contain sufficient information to constitute
an interim financial report as defined in Financial Accounting
Standards ASC 270, “Interim Financial Reporting.” The financial
information in this press release has not been audited.
Non-GAAP Financial MeasuresWe
present non-GAAP financial measures because we believe that they
and other similar measures are widely used by certain investors,
securities analysts and other interested parties as supplemental
measures of performance and liquidity. We also use these measures
internally to establish forecasts, budgets and operational goals to
manage and monitor our business, as well as evaluate our underlying
historical performance, as we believe that these non-GAAP financial
measures provide a more accurate depiction of the performance of
the business by encompassing only relevant and manageable events,
enabling us to evaluate and plan more effectively for the future.
The non-GAAP financial measures may not be comparable to other
similarly titled measures of other companies, have limitations as
analytical tools, and should not be considered in isolation or as a
substitute for analysis of our operating results as reported under
GAAP as issued by the Financial Accounting Standards Board
(“FASB”). Non-GAAP financial measures and ratios are not
measurements of our performance, financial condition or liquidity
under GAAP as issued by the FASB and should not be considered as
alternatives to operating profit or net income or as alternatives
to cash flow from operating, investing or financing activities for
the period, or any other performance measures, derived in
accordance with GAAP as issued by the FASB or any other generally
accepted accounting principles.
ibex is not providing a quantitative
reconciliation of forward-looking non-GAAP adjusted EBITDA margin
to the most directly comparable GAAP measure because it is unable
to predict with reasonable certainty the ultimate outcome of
certain significant items without unreasonable effort. These items
include, but are not limited to, non-recurring expenses, fair value
adjustments, and share-based compensation expense. These items are
uncertain, depend on various factors, and could have a material
impact on GAAP reported results for the guidance period.
About ibexibex helps the
world’s preeminent brands more effectively engage their customers
with services ranging from customer support, technical support,
inbound/outbound sales, business intelligence and analytics,
digital demand generation, and CX surveys and feedback
analytics.
Forward Looking Statements
In addition to historical information, this
release contains “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995. In some
cases, you can identify forward-looking statements by terminology
such as “believe,” “may,” “will,” “estimate,” “continue,”
“anticipate,” “intend,” “should,” “plan,” “expect,” “predict,”
“potential,” or the negative of these terms or other similar
expressions. These statements include, but are not limited to,
statements regarding our future financial and operating
performance, including our outlook and guidance, and our
strategies, priorities and business plans. Our expectations and
beliefs regarding these matters may not materialize, and actual
results in future periods are subject to risks and uncertainties
that could cause actual results to differ materially from those
projected. Factors that could impact our actual results include:
our ability to attract new business and retain key clients; our
profitability based on our utilization, pricing and managing costs;
the potential for our clients or potential clients to consolidate;
our clients deciding to enter into or further expand their
insourcing activities and current trends toward outsourcing
services may reverse; our ability to manage our international
operations, particularly in the Philippines, Jamaica, Pakistan and
Nicaragua; our ability to anticipate, develop and implement
information technology solutions that keep pace with evolving
industry standards and changing client demands; our ability to
recruit, engage, motivate, manage and retain our global workforce;
our ability to comply with applicable laws and regulations,
including those regarding privacy, data protection and information
security, employment and anti-corruption; the effect of
cyberattacks or cybersecurity vulnerabilities on our information
technology systems; our ability to realize the anticipated
strategic and financial benefits of our relationship with Amazon;
and other factors discussed in the “Risk Factors” described in our
periodic reports filed with the U.S. Securities and Exchange
Commission (“SEC”), including our annual reports on Form 10-K,
quarterly reports on Form 10-Q, and past filings on Form 20-F, and
any other risk factors we include in subsequent filings with the
SEC. Because of these uncertainties, you should not make any
investment decisions based on our estimates and forward-looking
statements. Except as required by law, we undertake no obligation
to publicly update any forward-looking statements for any reason
after the date of this press release whether as a result of new
information, future events or otherwise.
IR Contact: Michael
Darwal, EVP, Deputy CFO & Investor Relations, ibex,
michael.darwal@ibex.coMedia
Contact: Daniel Burris, Senior Director PR and
Communication, ibex, daniel.burris@ibex.co
IBEX
LimitedUnaudited Consolidated Statements
of Financial Position
($000s) |
June 30,2023 |
|
June 30,2022 |
Assets |
|
|
|
Current
assets |
|
|
|
Cash and cash equivalents |
$ |
57,429 |
|
|
$ |
48,831 |
|
Accounts receivable |
|
86,364 |
|
|
|
75,418 |
|
Prepaid expenses |
|
6,616 |
|
|
|
7,135 |
|
Due from related parties |
|
43 |
|
|
|
13 |
|
Tax advances and receivables |
|
5,965 |
|
|
|
6,390 |
|
Other current assets |
|
2,190 |
|
|
|
4,564 |
|
Total current
assets |
|
158,607 |
|
|
|
142,351 |
|
|
|
|
|
Non-current
assets |
|
|
|
Property and equipment, net |
|
41,151 |
|
|
|
41,939 |
|
Operating lease assets |
|
70,919 |
|
|
|
83,094 |
|
Goodwill |
|
11,832 |
|
|
|
11,832 |
|
Deferred tax asset, net |
|
4,585 |
|
|
|
9,276 |
|
Other non-current assets |
|
6,230 |
|
|
|
5,688 |
|
Total non-current
assets |
|
134,717 |
|
|
|
151,829 |
|
Total
assets |
$ |
293,324 |
|
|
$ |
294,180 |
|
|
|
|
|
Liabilities and
stockholders' equity |
|
|
|
Current
liabilities |
|
|
|
Accounts payable and accrued liabilities |
$ |
18,705 |
|
|
$ |
21,286 |
|
Accrued payroll and employee-related liabilities |
|
29,360 |
|
|
|
33,453 |
|
Current deferred revenue |
|
6,413 |
|
|
|
8,600 |
|
Current operating lease liabilities |
|
13,036 |
|
|
|
13,808 |
|
Current maturities of long-term debt |
|
413 |
|
|
|
15,079 |
|
Due to related parties |
|
2,314 |
|
|
|
2,583 |
|
Income taxes payable |
|
3,020 |
|
|
|
2,965 |
|
Total current
liabilities |
|
73,261 |
|
|
|
97,774 |
|
|
|
|
|
Non-current
liabilities |
|
|
|
Non-current deferred revenue |
|
1,383 |
|
|
|
3,993 |
|
Non-current operating lease liabilities |
|
64,854 |
|
|
|
75,994 |
|
Long-term debt |
|
600 |
|
|
|
661 |
|
Other non-current liabilities |
|
3,262 |
|
|
|
2,299 |
|
Total non-current
liabilities |
|
70,099 |
|
|
|
82,947 |
|
Total
liabilities |
|
143,360 |
|
|
|
180,721 |
|
|
|
|
|
Stockholders'
equity |
|
|
|
Common stock |
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
204,734 |
|
|
|
197,785 |
|
Treasury stock |
|
(3,682 |
) |
|
|
(3,406 |
) |
Accumulated other comprehensive loss |
|
(6,312 |
) |
|
|
(4,562 |
) |
Accumulated deficit |
|
(44,778 |
) |
|
|
(76,360 |
) |
Total stockholders'
equity |
|
149,964 |
|
|
|
113,459 |
|
Total liabilities and
stockholders' equity |
$ |
293,324 |
|
|
$ |
294,180 |
|
IBEX LimitedUnaudited
Consolidated Statements of Comprehensive Income
|
Three months ended June 30, |
|
Twelve months ended June 30, |
(000s, except per share amounts) |
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Revenue |
$ |
124,431 |
|
|
$ |
123,537 |
|
|
$ |
523,118 |
|
|
$ |
492,851 |
|
|
|
|
|
|
|
|
|
Cost of services |
|
87,356 |
|
|
|
91,779 |
|
|
|
374,992 |
|
|
|
373,973 |
|
Selling, general and
administrative |
|
23,717 |
|
|
|
21,278 |
|
|
|
88,663 |
|
|
|
80,153 |
|
Depreciation and
amortization |
|
5,052 |
|
|
|
5,014 |
|
|
|
18,985 |
|
|
|
18,100 |
|
Total operating expenses |
|
116,125 |
|
|
|
118,071 |
|
|
|
482,640 |
|
|
|
472,226 |
|
|
|
|
|
|
|
|
|
Income from
operations |
|
8,306 |
|
|
|
5,466 |
|
|
|
40,478 |
|
|
|
20,625 |
|
|
|
|
|
|
|
|
|
Interest income / (expense),
net |
|
10 |
|
|
|
(169 |
) |
|
|
(152 |
) |
|
|
(1,246 |
) |
Income before income
taxes |
|
8,316 |
|
|
|
5,297 |
|
|
|
40,326 |
|
|
|
19,379 |
|
|
|
|
|
|
|
|
|
Provision for income tax
(expense) / benefit |
|
(3,806 |
) |
|
|
1,124 |
|
|
|
(8,744 |
) |
|
|
2,077 |
|
Net
income |
$ |
4,510 |
|
|
$ |
6,421 |
|
|
$ |
31,582 |
|
|
$ |
21,456 |
|
|
|
|
|
|
|
|
|
Other comprehensive
income |
|
|
|
|
|
|
|
Foreign currency translation adjustments |
$ |
(72 |
) |
|
$ |
(1,265 |
) |
|
$ |
(2,234 |
) |
|
$ |
(2,281 |
) |
Cash flow hedge revaluation, net of tax |
|
(254 |
) |
|
|
(202 |
) |
|
|
515 |
|
|
|
(323 |
) |
Actuarial (loss) / gain on defined benefit plan |
|
(31 |
) |
|
|
440 |
|
|
|
(31 |
) |
|
|
440 |
|
Total other comprehensive
(loss) / income |
|
(357 |
) |
|
|
(1,027 |
) |
|
|
(1,750 |
) |
|
|
(2,164 |
) |
Total comprehensive
income |
$ |
4,153 |
|
|
$ |
5,394 |
|
|
$ |
29,832 |
|
|
$ |
19,292 |
|
|
|
|
|
|
|
|
|
Net income per
share |
|
|
|
|
|
|
|
Basic earnings per share |
$ |
0.25 |
|
|
$ |
0.35 |
|
|
$ |
1.74 |
|
|
$ |
1.18 |
|
Diluted earnings per
share |
$ |
0.24 |
|
|
$ |
0.35 |
|
|
$ |
1.67 |
|
|
$ |
1.15 |
|
|
|
|
|
|
|
|
|
Weighted average
common shares outstanding |
|
|
|
|
|
|
|
Basic |
|
18,259 |
|
|
|
18,148 |
|
|
|
18,200 |
|
|
|
18,232 |
|
Diluted |
|
18,989 |
|
|
|
18,555 |
|
|
|
18,893 |
|
|
|
18,724 |
|
IBEX LimitedUnaudited
Consolidated Statements of Cash Flows
|
Three months ended June 30, |
|
Twelve months ended June 30, |
($000s) |
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
CASH FLOWS FROM
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
Net income |
$ |
4,510 |
|
|
$ |
6,421 |
|
|
$ |
31,582 |
|
|
$ |
21,456 |
|
Adjustments to reconcile net income to net cash provided by
operating activities: |
|
|
|
|
|
|
|
Depreciation and amortization |
|
5,052 |
|
|
|
5,014 |
|
|
|
18,985 |
|
|
|
18,100 |
|
Noncash lease expense |
|
3,510 |
|
|
|
3,624 |
|
|
|
14,456 |
|
|
|
14,066 |
|
Warrant contra revenue |
|
234 |
|
|
|
259 |
|
|
|
1,090 |
|
|
|
970 |
|
Deferred income tax |
|
1,511 |
|
|
|
(2,614 |
) |
|
|
4,529 |
|
|
|
(5,170 |
) |
Share-based compensation expense |
|
633 |
|
|
|
555 |
|
|
|
4,606 |
|
|
|
1,851 |
|
Allowance of expected credit losses |
|
190 |
|
|
|
(62 |
) |
|
|
295 |
|
|
|
— |
|
Loss on lease terminations |
|
251 |
|
|
|
— |
|
|
|
251 |
|
|
|
— |
|
Gain on sale of subsidiaries |
|
— |
|
|
|
— |
|
|
|
(246 |
) |
|
|
— |
|
Change in assets and liabilities: |
|
|
|
|
|
|
|
(Increase) / decrease in accounts receivable |
|
5,549 |
|
|
|
11,013 |
|
|
|
(12,297 |
) |
|
|
(9,705 |
) |
Decrease / (increase) in prepaid expenses and other current
assets |
|
(775 |
) |
|
|
1,841 |
|
|
|
1,467 |
|
|
|
3,551 |
|
Increase / (decrease) in accounts payable and accrued
liabilities |
|
2,324 |
|
|
|
3,369 |
|
|
|
(3,753 |
) |
|
|
2,307 |
|
Increase / (decrease) in deferred revenue |
|
(2,076 |
) |
|
|
(823 |
) |
|
|
(4,797 |
) |
|
|
5,506 |
|
Decrease in operating lease liabilities |
|
(3,478 |
) |
|
|
(3,407 |
) |
|
|
(14,309 |
) |
|
|
(12,926 |
) |
Net cash inflow from operating activities |
|
17,435 |
|
|
|
25,190 |
|
|
|
41,859 |
|
|
|
40,006 |
|
|
|
|
|
|
|
|
|
CASH FLOWS FROM
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
Purchase of property and equipment |
|
(3,721 |
) |
|
|
(2,708 |
) |
|
|
(18,952 |
) |
|
|
(25,919 |
) |
Cash outflow from sale of subsidiaries, net of cash received |
|
— |
|
|
|
— |
|
|
|
(85 |
) |
|
|
— |
|
Net cash outflow from
investing activities |
|
(3,721 |
) |
|
|
(2,708 |
) |
|
|
(19,037 |
) |
|
|
(25,919 |
) |
|
|
|
|
|
|
|
|
CASH FLOWS FROM
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
Proceeds from line of credit |
|
58 |
|
|
|
12,901 |
|
|
|
43,448 |
|
|
|
88,117 |
|
Repayments of line of credit |
|
(56 |
) |
|
|
(24,500 |
) |
|
|
(54,597 |
) |
|
|
(99,227 |
) |
Repayment of debt |
|
— |
|
|
|
(1,411 |
) |
|
|
(3,795 |
) |
|
|
(6,834 |
) |
Proceeds from the exercise of options |
|
226 |
|
|
|
17 |
|
|
|
2,053 |
|
|
|
35 |
|
Principal payments on finance leases |
|
(94 |
) |
|
|
(73 |
) |
|
|
(447 |
) |
|
|
(818 |
) |
Purchase of treasury shares |
|
— |
|
|
|
(1,064 |
) |
|
|
(276 |
) |
|
|
(3,406 |
) |
Net cash (outflow) /
inflow from financing activities |
|
134 |
|
|
|
(14,130 |
) |
|
|
(13,614 |
) |
|
|
(22,133 |
) |
Effects of exchange rate difference on cash and cash
equivalents |
|
(95 |
) |
|
|
(971 |
) |
|
|
(610 |
) |
|
|
(965 |
) |
Net (decrease) / increase in cash and cash equivalents |
|
13,753 |
|
|
|
7,381 |
|
|
|
8,598 |
|
|
|
(9,011 |
) |
Cash and cash equivalents at beginning of the period |
|
43,676 |
|
|
|
41,450 |
|
|
|
48,831 |
|
|
|
57,842 |
|
Cash and cash
equivalents at end of the year |
$ |
57,429 |
|
|
$ |
48,831 |
|
|
$ |
57,429 |
|
|
$ |
48,831 |
|
IBEX
LimitedReconciliation of GAAP Financial Measures
to Non-GAAP Financial Measures
EXHIBIT 1: Adjusted net income and
adjusted earnings per shareWe define “adjusted net income”
as net income before the effect of the following items:
non-recurring expenses (including domestic filer conversion,
severance, legal and settlement, and Pandemic costs, as
applicable), warrant contra revenue, foreign currency gains or
losses, share-based compensation expense, gain or loss on sale of
subsidiaries and lease terminations, net of the tax impact of such
adjustments. We define “adjusted earnings per share” as
diluted earnings per share less the per share impact of adjustments
to net income. The following table provides a reconciliation of net
income to adjusted net income and diluted earnings per share to
adjusted earnings per share for the periods presented:
|
Three months ended June 30, |
|
Twelve months ended June 30, |
($000s, except per share amounts) |
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net
income |
$ |
4,510 |
|
|
$ |
6,421 |
|
|
$ |
31,582 |
|
|
$ |
21,456 |
|
Net income
margin |
|
3.6 |
% |
|
|
5.2 |
% |
|
|
6.0 |
% |
|
|
4.4 |
% |
|
|
|
|
|
|
|
|
Non-recurring expenses |
|
1,348 |
|
|
|
1,502 |
|
|
|
2,224 |
|
|
|
3,256 |
|
Warrant contra revenue |
|
234 |
|
|
|
259 |
|
|
|
1,090 |
|
|
|
970 |
|
Foreign currency gain |
|
(379 |
) |
|
|
(34 |
) |
|
|
(801 |
) |
|
|
(57 |
) |
Share-based compensation
expense |
|
633 |
|
|
|
555 |
|
|
|
4,606 |
|
|
|
1,851 |
|
Gain on sale of
subsidiaries |
|
— |
|
|
|
— |
|
|
|
(246 |
) |
|
|
— |
|
Gain on lease
terminations |
|
251 |
|
|
|
— |
|
|
|
251 |
|
|
|
— |
|
Total
adjustments |
$ |
2,087 |
|
|
$ |
2,282 |
|
|
$ |
7,124 |
|
|
$ |
6,020 |
|
Tax impact of
adjustments1 |
|
(370 |
) |
|
|
(416 |
) |
|
|
(1,760 |
) |
|
|
(1,427 |
) |
Adjusted net
income |
$ |
6,227 |
|
|
$ |
8,287 |
|
|
$ |
36,946 |
|
|
$ |
26,049 |
|
Adjusted net income
margin |
|
5.0 |
% |
|
|
6.7 |
% |
|
|
7.1 |
% |
|
|
5.3 |
% |
|
|
|
|
|
|
|
|
Diluted earnings per
share |
$ |
0.24 |
|
|
$ |
0.35 |
|
|
$ |
1.67 |
|
|
$ |
1.15 |
|
Per share impact of
adjustments to net income |
|
0.09 |
|
|
|
0.10 |
|
|
|
0.28 |
|
|
|
0.25 |
|
Adjusted earnings per
share |
$ |
0.33 |
|
|
$ |
0.45 |
|
|
$ |
1.96 |
|
|
$ |
1.39 |
|
|
Weighted average diluted shares outstanding |
|
18,989 |
|
|
|
18,555 |
|
|
|
18,893 |
|
|
|
18,724 |
|
_____
1The tax impact of each adjustment is calculated
using the effective tax rate in the relevant jurisdictions.
EXHIBIT 2: EBITDA, adjusted EBITDA, and
adjusted EBITDA marginWe define “EBITDA” as net income
before the effect of the following items: interest (income) /
expense, net, income tax expense / (benefit), and depreciation and
amortization. We define “adjusted EBITDA” as EBITDA before the
effect of the following items: non-recurring expenses
(including domestic filer conversion, severance, legal and
settlement, and Pandemic costs, as applicable), warrant contra
revenue, foreign currency gains, share-based compensation expense,
gain on disposal of subsidiaries and lease terminations. Adjusted
EBITDA margin is a non-GAAP profitability measure that represents
adjusted EBITDA divided by revenue. The following table provides a
reconciliation of net income to adjusted EBITDA for the periods
presented:
|
|
Three months ended June 30, |
|
Twelve months ended June 30, |
($000s) |
|
|
2023 |
|
|
|
2022 |
|
|
|
2023 |
|
|
|
2022 |
|
Net
income |
|
$ |
4,510 |
|
|
$ |
6,421 |
|
|
$ |
31,582 |
|
|
$ |
21,456 |
|
Net income
margin |
|
|
3.6 |
% |
|
|
5.2 |
% |
|
|
6.0 |
% |
|
|
4.4 |
% |
|
|
|
|
|
|
|
|
|
Interest (income) / expense,
net |
|
|
(10 |
) |
|
|
169 |
|
|
|
152 |
|
|
|
1,246 |
|
Income tax expense /
(benefit) |
|
|
3,806 |
|
|
|
(1,124 |
) |
|
|
8,744 |
|
|
|
(2,077 |
) |
Depreciation and
amortization |
|
|
5,052 |
|
|
|
5,014 |
|
|
|
18,985 |
|
|
|
18,100 |
|
EBITDA |
|
$ |
13,358 |
|
|
$ |
10,480 |
|
|
$ |
59,463 |
|
|
$ |
38,725 |
|
Non-recurring expenses |
|
|
1,348 |
|
|
|
1,502 |
|
|
|
2,224 |
|
|
|
3,256 |
|
Warrant contra revenue |
|
|
234 |
|
|
|
259 |
|
|
|
1,090 |
|
|
|
970 |
|
Foreign currency gain |
|
|
(379 |
) |
|
|
(34 |
) |
|
|
(801 |
) |
|
|
(57 |
) |
Share-based compensation
expense |
|
|
633 |
|
|
|
555 |
|
|
|
4,606 |
|
|
|
1,851 |
|
Gain on sale of
subsidiaries |
|
|
— |
|
|
|
— |
|
|
|
(246 |
) |
|
|
— |
|
Gain on lease
terminations |
|
|
251 |
|
|
|
— |
|
|
|
251 |
|
|
|
— |
|
Adjusted
EBITDA |
|
$ |
15,445 |
|
|
$ |
12,762 |
|
|
$ |
66,587 |
|
|
$ |
44,745 |
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA
margin |
|
|
12.4 |
% |
|
|
10.3 |
% |
|
|
12.7 |
% |
|
|
9.1 |
% |
EXHIBIT 3: Free cash flowWe
define “free cash flow” as net cash provided by operating
activities less capital expenditures.
|
Three months ended June 30, |
|
Twelve months ended June 30, |
|
2023 |
|
2022 |
|
2023 |
|
2022 |
($000s) |
|
|
|
|
|
|
|
Net cash provided by operating activities |
$ |
17,435 |
|
$ |
25,190 |
|
$ |
41,859 |
|
$ |
40,006 |
Less: capital
expenditures |
|
3,721 |
|
|
2,707 |
|
|
18,952 |
|
|
25,919 |
Free cash
flow |
$ |
13,714 |
|
$ |
22,483 |
|
$ |
22,907 |
|
$ |
14,087 |
EXHIBIT 4: Net cashWe define
“net cash” as total cash and cash equivalents less debt.
($000s) |
June 30,2023 |
|
June 30,2022 |
Cash and cash equivalents |
$ |
57,429 |
|
$ |
48,831 |
|
|
|
|
Debt |
|
|
|
Current |
$ |
413 |
|
$ |
15,079 |
Non-current |
|
600 |
|
|
661 |
Total debt |
$ |
1,013 |
|
$ |
15,740 |
Net cash |
$ |
56,416 |
|
$ |
33,091 |
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From Apr 2024 to May 2024
IBEX (NASDAQ:IBEX)
Historical Stock Chart
From May 2023 to May 2024